Innovative composite systems for enhancing plant polyphenol stability and bioavailability
Fengguang Pan,
No information about this author
Xianglin Liu,
No information about this author
Mengying Qiao
No information about this author
et al.
Food Science and Biotechnology,
Journal Year:
2025,
Volume and Issue:
34(9), P. 1819 - 1834
Published: Jan. 6, 2025
Language: Английский
Ferulic Acid: A Comprehensive Review
J. Purushothaman,
No information about this author
Md. Rizwanullah
No information about this author
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 28, 2024
Ferulic
acid
(FA),
a
phenolic
compound
abundant
in
the
cell
walls
of
seeds,
leaves,
and
roots
various
fruits,
vegetables,
cereals,
grains,
is
renowned
for
its
wide
range
biological
activities,
including
antioxidant,
anti-inflammatory,
antimicrobial,
anticancer
properties.
Despite
therapeutic
potential,
clinical
application
FA
hindered
by
challenges
such
as
poor
water
solubility,
limited
bioavailability,
rapid
metabolism,
instability
under
physiological
conditions.
To
address
these
issues,
nanotechnology
has
emerged
transformative
approach,
enhancing
FA's
pharmacokinetic
profile.
Various
nanoparticle-based
systems,
polymer-based
lipid-based
nanoparticles,
have
been
developed
to
encapsulate
FA.
These
systems
demonstrated
significant
improvements
stability,
with
studies
showing
enhanced
antioxidant
activity
controlled
release
profiles.
Further,
surface
engineering
nanoparticles
provides
targeted
drug/phytochemical
delivery
potential.
The
drugs/phytochemicals
significantly
enhances
efficacy
minimizes
systemic
side
effects.
This
review
explores
potential
FA,
limitations
application,
advancements
that
are
paving
way
effective
use.
Language: Английский
State-of-the-art surfactants as biomedical game changers: unlocking their potential in drug delivery, diagnostics, and tissue engineering
Karuppiah Nagaraj,
No information about this author
Subramaniam Kamalesu
No information about this author
International Journal of Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 125590 - 125590
Published: April 1, 2025
Language: Английский
Unveiling the role of nanoparticle-based therapeutic strategies for pulmonary drug delivery
Journal of Drug Delivery Science and Technology,
Journal Year:
2024,
Volume and Issue:
unknown, P. 106558 - 106558
Published: Dec. 1, 2024
Language: Английский
Sustained Delivery of Liraglutide Using Multivesicular Liposome Based on Mixed Phospholipids
Runpeng Zhang,
No information about this author
Xinyu Yao,
No information about this author
Siqi Gao
No information about this author
et al.
Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(2), P. 203 - 203
Published: Feb. 6, 2025
Background:
Although
peptides
are
widely
used
in
the
clinical
treatment
of
various
diseases
due
to
their
strong
biological
activity,
they
usually
require
frequent
injections
owing
poor
vivo
half-life.
Therefore,
there
is
a
need
for
sustained
peptide
formulations.
Methods:
In
this
study,
liraglutide
(Lir)
and
biocompatible
multivesicular
liposomes
(MVLs)
were
utilized
as
model
drug
sustained-release
carriers,
respectively.
The
release
rate
Lir-MVLs
was
controlled
by
changing
ratio
SPC
DEPC
with
different
phase
transition
temperatures
(PTT,
PTTSPC
=
−20
°C,
PTTDEPC
13
°C).
Results:
As
increased,
had
more
flexible
lipid
membranes,
poorer
structural
stabilization,
fewer
internal
vesicles
larger
particle
sizes,
contributing
faster
Lir.
After
subcutaneous
injection
Lir-MVLs,
blood
glucose
concentration
(BGC)
db/db
mice
decreased
levels.
When
SPC-DEPC
greater
than
85:15,
too
fast;
BGC
remained
below
16
mM
only
2–4
days,
while
when
slow,
case
less
50:50,
also
2–3
days.
However,
75:25,
could
be
maintained
8
indicating
that
properties
best
met
pharmacological
requirements
Conclusions:
This
study
investigated
effects
phospholipids
PTT
on
characteristics
provided
ideas
design
preparations.
Language: Английский
Advanced Drug Delivery Systems for Topical Insulin in Diabetic Wound Healing
Sheida Barkhordari,
No information about this author
Farangis Shahi,
No information about this author
Hossein Ali Khonakdar
No information about this author
et al.
ChemistrySelect,
Journal Year:
2024,
Volume and Issue:
9(44)
Published: Nov. 1, 2024
Abstract
Diabetes
mellitus
is
a
chronic
condition
characterized
by
impaired
insulin
production
or
utilization,
leading
to
serious
complications
such
as
diabetic
foot
ulcers
(DFUs).
DFUs
are
wounds
with
high
levels
of
inflammatory
cytokines,
arterial
occlusion,
and
persistent
infection,
often
resulting
in
significant
morbidity.
Traditional
treatment
methods,
including
debridement,
offloading,
infection
control,
have
shown
limited
success,
prompting
the
exploration
novel
therapeutic
strategies.
Insulin,
known
for
its
role
glucose
metabolism,
also
possesses
wound‐healing
properties
promoting
cell
proliferation,
protein
synthesis,
modulating
inflammation.
However,
systemic
administration
not
ideal
due
hypoglycemia
risks
difficulties
achieving
concentrations
at
wound
sites.
This
review
focuses
on
advanced
drug
delivery
systems
topical
application
dressings.
Various
platforms,
hydrogels,
nanoparticles,
liposomes,
microemulsions
been
developed
optimize
bioavailability,
protect
it
from
degradation,
ensure
controlled
release.
These
aim
enhance
management
addressing
multifactorial
nature
healing
patients.
The
provides
comprehensive
overview
current
advancements,
evaluates
efficacy
these
preclinical
clinical
studies,
discusses
challenges
future
perspectives
this
field.
By
highlighting
potential
innovative
approaches,
underscores
promise
improving
patient
outcomes.
Language: Английский
Recent progress and current status of surface engineered magnetic nanostructures in cancer theranostics
Bijaideep Dutta,
No information about this author
K.C. Barick,
No information about this author
P. A. Hassan
No information about this author
et al.
Advances in Colloid and Interface Science,
Journal Year:
2024,
Volume and Issue:
334, P. 103320 - 103320
Published: Oct. 30, 2024
Language: Английский
Trivalent Disulfide Unit-Masked System Efficiently Delivers Large Oligonucleotide
Lei Wang,
No information about this author
Xiao Liu,
No information about this author
Yiliang Wu
No information about this author
et al.
Molecules,
Journal Year:
2024,
Volume and Issue:
29(17), P. 4223 - 4223
Published: Sept. 5, 2024
Oligonucleotide
drugs
are
shining
in
clinical
therapeutics,
but
efficient
and
safe
delivery
systems
severely
limit
their
widespread
use.
A
disulfide
unit
technology
platform
based
on
dynamic
thiol
exchange
chemistry
at
the
cell
membrane
has
potential
for
drug
delivery.
However,
alteration
of
CSSC
dihedral
angle
induced
by
different
substituents
directly
affects
effectiveness
this
its
stability.
Previously,
we
constructed
a
trivalent
low
that
can
effectively
promote
cellular
uptake
small
molecules.
Here,
novel
unit-masked
oligonucleotide
hybrid
unit,
motivated
prodrug
design.
Cellular
imaging
results
showed
such
system
exhibited
superior
efficiency
than
commercial
Lipo2000
without
cytotoxicity.
The
reagents
significantly
reduced
(57–74%),
which
proved
to
be
endocytosis-independent.
In
addition,
vivo
distribution
experiments
mice
rapidly
distributed
liver
tissues
with
duration
action
more
24
h,
representing
means
silencing
genes
involved
pathogenesis
liver-like
diseases.
conclusion,
deliver
large
drugs.
Language: Английский